Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma

Author： Smit J.J.   Van Loveren H.   Hoekstra M.O.   Van der Kant P.A.A.   Folkerts G.   Nijkamp F.P.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.470, Iss.3, 2003-06, pp. : 193-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allergic Asthma: A Summary from Genetic Basis, Mouse Studies, to Diagnosis and Treatment

By  

Current Pharmaceutical Design, Vol. 22, Iss. 41, 2016-12 ,pp. : 6261-6272

Bentham Science Publishers

Access to resources Recommend Favorite

Eotaxin protein levels and airway pathology in a mouse model for allergic asthma

By Scheerens J.   van Gessel S.B.E.   Nijkamp F.P.   Folkerts G.  

European Journal of Pharmacology, Vol. 453, Iss. 1, 2002-10 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

By  

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 1, Iss. 1, 2014-04 ,pp. : 2-10

Bentham Science Publishers

Access to resources Recommend Favorite

Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal

By Burch Jane  

PharmacoEconomics, Vol. 30, Iss. 11, 2012-11 ,pp. : 991-1004

Adis International

Access to resources Recommend Favorite

QOL improves with additional SRL 172 in NSCLC

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 454, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite